Objective: Analyzing the medication law of external prescriptions for the treatment of osteoarthritis in royal formulary of the Qing dynasty books edited by academician CHEN Ke-ji by using data mining software and network pharmacology. Methods: Selected the external prescriptions for the treatment of osteoarthritis from the books, and use excel software to build a database, based on the TCM inheritance assistance platform (V3.0), the frequency of TCM use and its taste, meridian and efficacy were counted, and then the association rules and clusters of prescriptions were analyzed. Combined with professional knowledge, a new formula (Rongjinqubi prescription) was formed, and the feasibility of Rongjinqubi prescription in the treatment of osteoarthritis was proved by the network pharmacology. Result: Based on 103 external prescriptions for the treatment of osteoarthritis was selected from the books and the frequency statistics showed that the common topical drugs were mainly Frankincense, Angelica sinensis, Myrrh and Fangfeng, etc. Whose the tropism of taste was warm, flat, spicy, bitter, into the liver, spleen. Based on this analysis, the core combinations were clustered according to the association rules of TCM. Comprehensive the results above set new prescription (Rongjinqubi prescription). Conclusion: Royal formulary of the Qing Dynasty series of books for the treatment of osteoarthritis is mainly to promote blood circulation and remove blood stasis, dispel wind and dehumidification, and to tonifying the liver and kidney. Using drugs' regularity is consistent with the characteristics of the pathogenesis of osteoarthritis in TCM, which generates the intermediate pathological product of blood stasis due to the experience of wind chill and dampness, liver and kidney deficiency due to internal causes. Based on this analysis, the core combination of TCM clustering has a reference value for the treatment of osteoarthritis. On this basis, the new prescription (Rongjinqubi prescription) verified by network pharmacology provides therapeutic value for the treatment of osteoarthritis. |